drugset / Trial / NCT06447194

Effect of RECK in Posterior Spinal Fusion

NCT06447194

Phase 1/2 Withdrawn University of Maryland, Baltimore
RandomizedParallel-groupQuadruple-blindTreatment

Summary

"RECK" is a combination of local anesthesia medications, used for the purpose of pain control. RECK is an acronym which stands for Ropivacaine, Epinephrine, Clonidine, and Ketorolac. The purpose of this study is to investigate the effect of RECK local injectable anesthetic in the setting of posterior spinal fusion. Our specific aims are the following. Primary aim: to investigate the effect of RECK local injectable anesthetic on postoperative VAS pain scores. Secondary aims: to investigate of effect of RECK injection on postoperative opioid consumption and hospital length of stay. Hypothesis: RECK injection will significantly decrease postoperative VAS pain score, opioid consumption, and hospital length of stay compared to placebo controls.

Timeline

Start
2025-10-01
Primary completion
2027-01-01
Completion
2027-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 80 ug Intramuscular
Subject Epinephrine Other / unclassified 0.5 mg Intramuscular
Subject Ketorolac Other / unclassified 30 mg Intramuscular
Subject Ropivacaine Other / unclassified 0.125 g Intramuscular